Healthequity (HQY) earnings history
Most recent quarter
- Fiscal period
- Q2 2027
- Period end
- Jul 31, 2026
- EPS actual
- $1.24
- EPS estimate
- $1.19
- EPS surprise
- +3.92%
- Revenue surprise
- +0.42%
- Revenue
- $350.7M
- Revenue estimate
- $349.2M
- Reported
- Aug 27, 2026
HealthEquity reported fiscal Q2 2027 results on August 27, 2026, for the quarter ended July 31, 2026. Earnings per share were $1.24, beating the $1.19 estimate by 3.92%. Revenue was $350.7 million, just above the $349.2 million consensus. Compared with fiscal Q2 2026, EPS rose about 15% from $1.08 and revenue rose about 7.6% from $325.8 million.
Earnings have climbed steadily. Annual EPS went from $1.35 in fiscal 2023 to $2.26 in fiscal 2024, $3.13 in fiscal 2025 and $4.01 in fiscal 2026, nearly three times the fiscal 2023 level. The first half of fiscal 2027 totals $2.48 per share, about 21% more than the $2.05 a year earlier. Fiscal Q1 and Q2 2027 share the EPS high in the table at $1.24, and fiscal Q1 2027 set the revenue high at $354.6 million. HealthEquity beat EPS estimates in 17 of the last 20 quarters, including each of the last six.
Fiscal Q3 results were reported between December 3 and December 9 in each of the past four years. That points to early December 2026 for the next report, which will show whether the year-over-year EPS growth seen this year carries into the third quarter.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2027 | Aug 27, 2026 | $1.19 | $1.24 | +3.92% | $350.7M | SEC |
| Q1 2027 | May 28, 2026 | $1.11 | $1.24 | +11.23% | $354.6M | SEC |
| Q4 2026 | Mar 17, 2026 | $0.90 | $0.95 | +5.83% | $334.6M | SEC |
| Q3 2026 | Dec 3, 2025 | $0.91 | $1.01 | +10.71% | $322.2M | SEC |
| Q2 2026 | Sep 2, 2025 | $0.91 | $1.08 | +18.14% | $325.8M | SEC |
| Q1 2026 | Jun 3, 2025 | $0.81 | $0.97 | +19.34% | $330.8M | SEC |
| Q4 2025 | Mar 18, 2025 | $0.72 | $0.69 | −3.63% | $311.8M | SEC |
| Q3 2025 | Dec 9, 2024 | $0.72 | $0.78 | +7.99% | $300.4M | SEC |
| Q2 2025 | Sep 3, 2024 | $0.70 | $0.86 | +23.03% | $299.9M | SEC |
| Q1 2025 | Jun 3, 2024 | $0.66 | $0.80 | +21.88% | $287.6M | SEC |
| Q4 2024 | Mar 19, 2024 | $0.57 | $0.63 | +10.94% | $262.4M | SEC |
| Q3 2024 | Dec 5, 2023 | $0.50 | $0.60 | +20.02% | $249.2M | SEC |
| Q2 2024 | Sep 5, 2023 | $0.48 | $0.53 | +11.11% | $243.5M | SEC |
| Q1 2024 | Jun 5, 2023 | $0.41 | $0.50 | +23.37% | $244.4M | SEC |
| Q4 2023 | Mar 21, 2023 | $0.35 | $0.37 | +5.96% | $233.8M | SEC |
| Q3 2023 | Dec 6, 2022 | $0.35 | $0.38 | +9.64% | $216.1M | SEC |
| Q2 2023 | Sep 6, 2022 | $0.33 | $0.33 | −0.06% | $206.1M | SEC |
| Q1 2023 | Jun 6, 2022 | $0.26 | $0.27 | +3.85% | $205.7M | SEC |
| Q4 2022 | Mar 22, 2022 | $0.21 | $0.20 | −6.80% | $203.3M | SEC |
| Q3 2022 | Dec 6, 2021 | $0.35 | $0.35 | +0.92% | $180.0M | SEC |
Quarterly revenue
Frequently asked questions
When did Healthequity (HQY) last report earnings?
Healthequity last reported on Aug 27, 2026, covering fiscal Q2 2027.
Did HQY beat earnings estimates?
Yes. Healthequity reported EPS of $1.24 for Q2 2027 against a $1.19 estimate — a 3.92% beat.
How much revenue did HQY report last quarter?
Healthequity reported $350.7M in revenue for Q2 2027, against a consensus estimate of $349.2M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.